Titan Biotech LimitedBSE: TITANBIO

Board Meeting Intimation for Consideration & Approval Of The Audited (Standalone & Consolidated) Financial Results For The Quarter And Financial Year Ended March 31, 2025 And Consideration Of Recommendation Of Final Dividend, If Any For The Financial

May 26, 2025 at 2:54 AM EDT · Issued by Titan Biotech Limited via BSE India

Filed with BSE · May 26, 2025 at 2:54 AM EDT

On 6ix: 6ix.com/news/board-meeting-intimation-for-consideration-and-approval-of-the-audited-standalone-and-consolidated-financial-results-for-the-quarter-and-financial-year-ended-march-31-2025-and-consideration-of-recommendation-of-final-dividend-if-any-for-the-financial

Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the Audited (Standalone and Consolidated) Financial Results for the Quarter and Financial Year ended March 31, 2025 and to consider recommendation of Final Dividend, if any, for the Financial Year ended March 31, 2025.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Titan Biotech Limited on 6ix

Story so far

Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Financial Results For Quarter Ending On 31St December, 2024Feb 3, 2025

Board Meeting Intimation for Consideration & Approval Of The Audited (Standalone & Consolidated) Financial Results For The Quarter And Financial Year Ended March 31, 2025 And Consideration Of Recommendation Of Final Dividend, If Any For The Financial

Story so far

Earlier from Titan Biotech

Later from Titan Biotech